Provides care for those with suspected or known bleeding disorders.
This program provides care for the following:
- congenital bleeding disorders
- women with bleeding disorders
- acquired bleeding disorders
- hemoglobinopathy i.e Sickle Cell Disease, Hemoglobin H Disease, Thalessemia (Major/Intermedia)
- hereditary angioedema (HAE)
- paroxysmal nocturnal hemoglobinuria (PNH)
- transfusion dependent congenital bone marrow failure syndromes
The multidisciplinary team provides comprehensive care to manage and improve outcomes and patient / family quality of life through patient-centered evidence based care, education and research. In addition the team supervises and manages the delivery of home-infusion blood products for appropriate patients.